Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02883491 · ClinicalTrials.gov registry record
Pulmonary Embolism Short-term Clinical Outcomes Registry
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 815
- Enrollment target
NCT02883491 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 815 participants.
The verdict
NCT02883491 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 815 participants
- Enrollment target
Study Summary
The overall goal of this clinical research study is to prospectively assess primary outcomes related to pulmonary embolism (PE) that occur immediately (within 5 days) and within 30 days. The secondary goal is to compare validated prediction models and a modified European Society of Cardiology (ESC) approach that is primarily right ventricle dysfunction (RVD) driven with clinical risk assessment being secondary, and with primary outcomes of clinical deterioration within 5 days.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 815 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-02-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02883491
The ClinicalTrials.gov registry entry for NCT02883491 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 815 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02883491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02883491 about?
NCT02883491 is a clinical study titled "Pulmonary Embolism Short-term Clinical Outcomes Registry". The overall goal of this clinical research study is to prospectively assess primary outcomes related to pulmonary embolism (PE) that occur immediately (within 5 days) and within 30 days. The secondary goal is to compare validated prediction models and a modified European Society of Cardiology (ESC) ...
What is the current status of trial NCT02883491?
This trial is currently completed. The enrollment target is 815 participants. The study started on 2016-08. Estimated completion is 2019-02-20.
Who is sponsoring clinical trial NCT02883491?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.